LOS ANGELES--(BUSINESS WIRE)-- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Neumora Therapeutics, Inc. (“Neumora” or “the Company”) (NASDAQ: NMRA) for violations of the federal securities laws.

Investors who purchased the Company's securities pursuant and/or traceable to the Company’s Offering Documents in connection with its initial public offering (“IPO”) conducted on September 15, 2023, are encouraged to contact the firm before April 7, 2025.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at bschall@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Neumora justified conducting its Phase Three Program on Navacaprant by amending BlackThorn’s Phase Two Trial to include a patient population with moderate to severe major depressive disorder (“MDD”). The Company also added a prespecified analysis of patients with moderate to severe MDD. The Phase Two Trials lacked an adequate level of data especially on population size and gender ratio to accurately predict the outcome of its KOASTAL-1 study. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Neumora, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250212935146/en/